Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60000 participants
INTERVENTIONAL
2020-10-02
2021-05-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main out-come will be participation within 6 months after invitation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of a Colorectal Cancer Screening Decision Aid Tailored to Lower Educational Attainment Citizens
NCT03253822
Interventions to Improve Bowel Cancer Screening Uptake in Ireland: a 2x2 Factorial Trial
NCT05609396
IMPROVE: Circulating Tumor DNA Analysis to Optimize Treatment for Patients With Colorectal Cancer
NCT03637686
Exploring Participant Preference for Screening Methods and Experience Into Colorectal Cancer Screening Programme
NCT06696534
Assessing Repeat Fit Testing for CRC
NCT03248661
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention arm I
pre-notification approximately ten days prior to intervention, invitation and one reminder (three-staged intervention)
Invitation procedure
Optimised invitation procedures in an organised colorectal cancer screening programme
Intervention arm II
invitation, one reminder after 45 days and a second reminder three months after invitation (three-staged invitation procedure)
Invitation procedure
Optimised invitation procedures in an organised colorectal cancer screening programme
Intervention arm III
pre-notification, invitation, reminder after 45 days and reminder after three months (four-staged invitation procedure)
Invitation procedure
Optimised invitation procedures in an organised colorectal cancer screening programme
Control group
invitation and one reminder after 45 days (usual care)
Invitation procedure
Optimised invitation procedures in an organised colorectal cancer screening programme
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Invitation procedure
Optimised invitation procedures in an organised colorectal cancer screening programme
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
50 Years
74 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Berit Andersen, Professor
Role: STUDY_DIRECTOR
Randers Regional Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Randers Regional Hospital
Randers, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Larsen MB, Hedelund M, Flander L, Andersen B. The impact of pre-notifications and reminders on participation in colorectal cancer screening - A randomised controlled trial. Prev Med. 2022 Nov;164:107229. doi: 10.1016/j.ypmed.2022.107229. Epub 2022 Aug 31.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
participationCRC2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.